DOP006 Ileocaecal resection versus infliximab for ileal Crohn’s disease: 10-year follow-up of the LIR!C trial
Anouck Haanappel(Amsterdam Neuroscience), LIR!C study group, Lotte Oldenburg(Amsterdam Neuroscience), C Bosman(Amsterdam Neuroscience), W Bemelman(Amsterdam Neuroscience), C J Buskens(Amsterdam Neuroscience), Mahsoem Ali(Amsterdam Neuroscience), G D’Haens(Amsterdam Neuroscience), Cyriel Ponsioen
Cited by 0
Related Papers
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data
|EClinicalMedicine|2022|76
Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms
|NEJM Evidence|2025|27
Effects of Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy
|JAMA Surgery|2024|22
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers
|JAMA Network Open|2023|17